LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model

• Main Authors: Po-Cheng Chang (Author), Shien-Fong Lin (Author), Yen Chu (Author), Hung-Ta Wo (Author), Hui-Ling Lee (Author), Yu-Chang Huang (Author), Ming-Shien Wen (Author), Chung-Chuan Chou (Author)
• Format: Book
• Published: Hindawi-Wiley, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. LCZ696 (valsartan/sacubitril) therapy significantly reduced mortality in patients with heart failure (HF). Although a clinical trial (PARADISE-MI Trial) has been ongoing to examine the effects of LCZ696 in myocardial infarction (MI) patients, the effects of LCZ696 on remodeling of cardia...